Quick-Med Technologies, Inc.

QMDT

US74837Q1067

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 09:40:26 19/04/2024 pm IST			5-day change	1st Jan Change
0.0001 ^USD	+9,900.00%		-.--%	-50.00%

2014	Quick-Med Technologies Inc. Signs License with Medline Industries, Inc. to Provide Stay-Fresh(R) Antimicrobial Technology for Traditional Wound Care Products	CI
2014	Quick-Med Technologies, Inc. Licenses its Stay Fresh Technology to Sarasota Medical Products for Use in Ostomy and Wound Care Products	CI

Quick-Med Technologies Inc. Announces Resignation of George Friel as a Member of Board of Directors

November 14, 2012 at 02:58 am IST

Effective November 6, 2012, Major General George Friel (Ret.) resigned as a member of its Board of Directors of Quick-Med Technologies Inc.

Latest news about Quick-Med Technologies, Inc.

Quick-Med Technologies Inc. Signs License with Medline Industries, Inc. to Provide Stay-Fresh(R) Antimicrobial Technology for Traditional Wound Care Products	28/14/28	CI
Quick-Med Technologies, Inc. Licenses its Stay Fresh Technology to Sarasota Medical Products for Use in Ostomy and Wound Care Products	14/14/14	CI
Quick-Med Technologies Inc. Auditor Raises 'Going Concern' Doubt	30/13/30	CI
Quick-Med Technologies Inc. Signs License with Polartec, LLC	27/13/27	CI
FDA Clears Quick-Med Technologies Inc.'s Stay-Fresh(R) Medical Textile Product	29/13/29	CI
Quick-Med Technologies Wins Contract to Develop Wound Healing Technology to Control Scar Contracture in Burn Patients	22/13/22	CI
Quick-Med Technologies Inc. Announces Expanded Global Distribution of Advanced Dressings with NIMBUS (R) Technology	14/13/14	CI
Quick-Med Technologies Inc. Announces Board Appointments	28/13/28	CI
Quick-Med Technologies Inc. Announces Resignation of Ladd Greeno as Member and Chairman of the Board of Directors	02/13/02	CI
Quick-Med Technologies Inc. Announces Executive Changes	16/13/16	CI
Quick-Med Technologies Inc. Announces Update on Appointment of John W. Sheets as Director	15/13/15	CI
Quick-Med Announces Commercial Sale of Advanced Dressings with NIMBUS(R) Technology	08/13/08	CI
Quick-Med Technologies Inc. Appoints John W. Sheets, Jr. as Board of Director	14/12/14	CI
Quick-Med Technologies Inc. Announces Resignation of George Friel as a Member of Board of Directors	14/12/14	CI
Quick-Med Technologies Inc. Auditor Raises 'Going Concern' Doubt	29/12/29	CI
Quick-Med Technologies to Receive US Patent on Novel Antimicrobial Technology Based on Hydrogen Peroxide	13/12/13	CI
Quick-Med Technologies Inc. Announces Expanded Regulatory Clearance for Stay Fresh(R) Antimicrobial	08/12/08	CI
Quick-Med Technologies Inc. Announces Management Changes	31/12/31	CI
Derma Sciences Inc. Enters Patent and Technology License Agreement with Quick-Med Technologies Inc	19/12/19	CI
Derma Sciences Acquires Global Long-Term Exclusive Rights to Nimbus Technology from Quick-Med Technologies Inc	13/12/13	CI
Quick-Med Technologies Signs Patent and Technology License Agreement with Doris Hosiery Mills, Limited	07/12/07	CI
Quick-Med Technologies Inc. Expands NIMBUS(R) Technology into Advanced Wound Care Dressings	14/12/14	CI

Chart Quick-Med Technologies, Inc.

Duration

Period

More charts

Quick-Med Technologies, Inc. is a life sciences company. The Company is focused on developing technologies for infection prevention and control in the consumer and healthcare markets. The Company offers four technologies, including NIMBUS, Stay Fresh, NimbuDerm and MultiStat. NIMBUS is a family of advanced polymers bioengineered for antimicrobial, hemostatic, and other properties that can be used in a range of medical device applications, including wound dressings, medical textiles, catheters, tubing, films and coatings. Stay Fresh is a chemical formulation for textiles with a durable antimicrobial agent effective against an array of bacteria even after numerous laundering cycles. NimbuDerm is a copolymer for application as a persistent hand sanitizer with long lasting protection against germs. MultiStat is a family of patented methods and compounds shown to be effective in skin therapy applications.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
QUICK-MED TECHNOLOGIES, INC.	-50.00%	3.73K
MODERNA, INC.	+17.96%	44.96B
IQVIA HOLDINGS INC.	+1.17%	42.65B
LONZA GROUP AG	+48.77%	41.85B
CELLTRION, INC.	-4.27%	29.04B
ICON PUBLIC LIMITED COMPANY	+11.42%	26.08B
ALNYLAM PHARMACEUTICALS, INC.	-21.39%	19.03B
BIO-TECHNE CORPORATION	+4.86%	12.75B
MEDPACE HOLDINGS, INC.	+27.29%	12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.50%	11.75B

Other Biotechnology & Medical Research